classifying xylazine as a schedule III controlled drug.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 12 Sponsors 10

As Amended by the Senate Apr 23, 2026 · 551 words Open full page ↗

SB 465-FN - AS AMENDED BY THE SENATE

03/05/2026 0842s

2026 SESSION

26-2002

09/05

SENATE BILL 465-FN

AN ACT classifying xylazine as a schedule III controlled drug.

SPONSORS: Sen. Gannon, Dist 23; Sen. Abbas, Dist 22; Sen. Birdsell, Dist 19; Sen. Carson,

Dist 14; Sen. Rochefort, Dist 1; Sen. McConkey, Dist 3; Rep. L. Walsh, Rock. 15;

Rep. Vose, Rock. 5; Rep. Roy, Rock. 31; Rep. Rhodes, Ches. 17

The document summary and details above are public. The full text is available to signed-in accounts.